COMPOUNDING FINDER
Tirzepatide is a dual GIP/GLP-1 receptor agonist prescribed for type 2 diabetes and chronic weight management. New Jersey patients with a documented clinical need may be eligible for compounded tirzepatide.
New Jersey has a dense healthcare network with proximity to both New York City and Philadelphia medical centers. Compounding Finder helps New Jersey residents compare licensed pharmacies statewide.
Yes. The New Jersey Board of Pharmacy oversees compounding. A valid prescription with clinical justification is required.
Typically $150 to $450 per month.